CD48 is a Counter-receptor for Mouse CD2 and is Involved in T Cell Activation
Overview
General Medicine
Affiliations
CD2 is an intercellular adhesion molecule that has been implicated in T cell activation and differentiation both in humans and mice. Although the ligand for human CD2 has been defined as LFA-3, that for murine CD2 has not been identified yet. To identify the ligand for mouse CD2, we generated a chimeric molecule consisting of the extracellular domain of mouse CD2 and human immunoglobulin (Ig)G1 Fc (mCD2Rg). A hamster monoclonal antibody (mAb), HM48-1, was established by screening mAbs that could block the binding of mCD2Rg to T cell lines at the ligand site. The putative mouse CD2 ligand recognized by this mAb was a glycosyl phosphatidylinositol-anchored glycoprotein with an apparent molecular mass of 45 kD, which were shared characteristics with human LFA-3. However, its expression was predominantly restricted to hematopoietic cells, unlike human LFA-3. Protein microsequencing analysis for the NH2-terminal 18 amino acid residues of the affinity-purified HM48-1 antigen revealed that it is almost identical with mouse CD48. This identity was further confirmed by the reactivity of HM48-1 with a soluble recombinant CD48 (sCD48) protein and the molecule recognized by a rat mAb raised against sCD48. A rat anti-CD48 mAb blocked the mCD2Rg binding as well as HM48-1. Moreover, sCD48 also inhibited the mCD2Rg binding to the cellular ligand. Finally, like anti-CD2 mAb, HM48-1 inhibited the phytohemagglutinin response and, when crosslinked, augmented the anti-CD3 response of splenic T cells. These results indicate that CD48 is a ligand for mouse CD2 and is involved in regulating T cell activation.
Cancer ATF4-mediated CD58 endocytosis impairs anti-tumor immunity and immunotherapy.
Zeng H, Yu J, Wang H, Shen M, Zou X, Zhang Z J Transl Med. 2025; 23(1):225.
PMID: 40001116 PMC: 11863482. DOI: 10.1186/s12967-025-06245-4.
Spaceflight alters host-gut microbiota interactions.
Gonzalez E, Lee M, Tierney B, Lipieta N, Flores P, Mishra M NPJ Biofilms Microbiomes. 2024; 10(1):71.
PMID: 39209868 PMC: 11362537. DOI: 10.1038/s41522-024-00545-1.
Yu Y, Lien W, Lin W, Pan Y, Huang S, Mou C Adv Sci (Weinh). 2024; 11(33):e2310204.
PMID: 38937984 PMC: 11434130. DOI: 10.1002/advs.202310204.
Eradication of CD48-positive tumors by selectively enhanced YTS cells harnessing the lncRNA NeST.
Kotzur R, Stein N, Kahlon S, Berhani O, Isaacson B, Mandelboim O iScience. 2023; 26(8):107284.
PMID: 37609636 PMC: 10440710. DOI: 10.1016/j.isci.2023.107284.
SLAM-family receptors come of age as a potential molecular target in cancer immunotherapy.
Farhangnia P, Ghomi S, Mollazadehghomi S, Nickho H, Akbarpour M, Delbandi A Front Immunol. 2023; 14:1174138.
PMID: 37251372 PMC: 10213746. DOI: 10.3389/fimmu.2023.1174138.